BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$4.89B |
| 2 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$2.11B |
| 3 |
Cigna
CI
|
+$2.09B |
| 4 |
ExxonMobil
XOM
|
+$1.33B |
| 5 |
Verizon
VZ
|
+$1.32B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$4.73B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$3.38B |
| 3 |
PX
Praxair Inc
PX
|
+$2.8B |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$2.28B |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.96% |
| 2 | Healthcare | 14.79% |
| 3 | Financials | 14.43% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Industrials | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LL
2301
DELISTED
LL Flooring Holdings, Inc.
LL
| $45.2M | ﹤0.01% |
4,749,908
+230,871
| +5% | +$2.79M |
|
|
PS
2302
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $45.2M | ﹤0.01% |
1,917,779
+142,072
| +8% | +$3.28M |
|
2303
GSK
GSK
$104B
| $45.1M | ﹤0.01% |
945,233
-192,429
| -17% | -$9.48M |
|
|
JCP
2304
DELISTED
J.C. Penney Company, Inc.
JCP
| $45.1M | ﹤0.01% |
43,382,574
+991,873
| +2% | +$1.39M |
|
2305
AMC Entertainment Holdings
AMC
$2.16B
| $45M | ﹤0.01% |
366,850
+10,528
| +3% | +$1.72M |
|
2306
Collegium Pharmaceutical
COLL
$889M
| $45M | ﹤0.01% |
2,619,718
+210,145
| +9% | +$3.6M |
|
2307
iShares International Equity Factor ETF
INTF
$3.74B
| $45M | ﹤0.01% |
1,896,475
+135,963
| +8% | +$3.46M |
|
|
REN
2308
DELISTED
Resolute Energy Corporaton
REN
| $45M | ﹤0.01% |
1,551,337
+74,989
| +5% | +$2.37M |
|
|
THR
2309
DELISTED
Thermon Group Holdings
THR
| $44.8M | ﹤0.01% |
2,210,775
+70,482
| +3% | +$1.59M |
|
|
CHUY
2310
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $44.8M | ﹤0.01% |
2,527,198
+74,094
| +3% | +$1.67M |
|
2311
PUT
AB InBev
BUD
$163B
| $44.8M | ﹤0.01% |
+680,100
| New | +$52M |
|
2312
Stratasys
SSYS
$771M
| $44.7M | ﹤0.01% |
2,483,425
+107,594
| +5% | +$2.25M |
|
2313
MACOM Technology Solutions
MTSI
$23.4B
| $44.7M | ﹤0.01% |
3,077,685
+87,704
| +3% | +$1.41M |
|
2314
Omeros
OMER
$966M
| $44.4M | ﹤0.01% |
3,989,206
+31,270
| +0.8% | +$438K |
|
2315
Herc Holdings
HRI
$5.67B
| $44.2M | ﹤0.01% |
1,702,303
+105,654
| +7% | +$3.68M |
|
2316
iShares US Treasury Bond ETF
GOVT
$43.6B
| $44.1M | ﹤0.01% |
1,788,278
+264,770
| +17% | +$6.44M |
|
|
TPC
2317
Tutor Perini Cor
TPC
$5.27B
| $44M | ﹤0.01% |
2,753,232
+188,564
| +7% | +$3.28M |
|
|
NCOM
2318
DELISTED
National Commerce Corporation
NCOM
| $43.7M | ﹤0.01% |
1,213,335
+108,977
| +10% | +$4.15M |
|
|
EVOP
2319
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $43.7M | ﹤0.01% |
1,769,998
+791,431
| +81% | +$19.5M |
|
2320
Modine Manufacturing
MOD
$10.3B
| $43.6M | ﹤0.01% |
4,033,058
-114,520
| -3% | -$1.46M |
|
2321
Applied Optoelectronics
AAOI
$11.5B
| $43.6M | ﹤0.01% |
2,823,899
+22,134
| +0.8% | +$446K |
|
2322
iShares Russell 2000 Value ETF
IWN
$14.5B
| $43.4M | ﹤0.01% |
403,497
-44,694
| -10% | -$5.38M |
|
2323
German American Bancorp
GABC
$1.86B
| $43.4M | ﹤0.01% |
1,562,344
+24,721
| +2% | +$768K |
|
2324
MacroGenics
MGNX
$259M
| $43.2M | ﹤0.01% |
3,401,391
+176,135
| +5% | +$2.95M |
|
2325
Assembly Biosciences
ASMB
$528M
| $43.2M | ﹤0.01% |
159,126
+5,296
| +3% | +$1.53M |
|
Similar funds
BlackRock's Q4 2018 Portfolio in Review
As of Q4 2018, BlackRock held 5,211 positions worth $1.98T, down 14% from $2.31T the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock's Q4 2018 filing shows 169 new, 3,017 increased, 1,308 reduced and 195 closed positions. Its largest new stake was Linde: 30,937,347 shares worth $4.83B. The largest sale was Aetna Inc, an estimated $4.73B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q4 2018 buy was Linde: 30,937,347 shares worth $4.83B.
- BlackRock added most to iShares Core MSCI Total International Stock ETF in Q4 2018, an estimated $2.11B increase.
- BlackRock's biggest Q4 2018 reduction was iShares Russell 1000 ETF, cutting an estimated $2.28B.
- BlackRock fully exited Aetna Inc in Q4 2018, selling an estimated $4.73B.
- BlackRock's ten largest holdings make up 14% of its $1.98T portfolio in Q4 2018.
- BlackRock opened 169 new positions and closed 195 in Q4 2018.
- BlackRock's portfolio value fell 14% quarter-over-quarter to $1.98T.
Based on BlackRock's 13F filing for Q4 2018, filed 8 Feb 2019.